Catalent Inc
NYSE:CTLT
Catalent Inc
Common Stock
Catalent Inc
Common Stock Peer Comparison
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Catalent Inc
NYSE:CTLT
|
Common Stock
$2m
|
CAGR 3-Years
-82%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
Johnson & Johnson
NYSE:JNJ
|
Common Stock
$3.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Common Stock
$292m
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Pfizer Inc
NYSE:PFE
|
Common Stock
$480m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Merck & Co Inc
NYSE:MRK
|
Common Stock
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Eli Lilly and Co
NYSE:LLY
|
Common Stock
$594.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
See Also
What is Catalent Inc's Common Stock?
Common Stock
2m
USD
Based on the financial report for Mar 31, 2024, Catalent Inc's Common Stock amounts to 2m USD.
What is Catalent Inc's Common Stock growth rate?
Common Stock CAGR 10Y
7%
Over the last year, the Common Stock growth was 0%. The average annual Common Stock growth rates for Catalent Inc have been -82% over the past three years , and 7% over the past ten years .